Status:
UNKNOWN
Comparison of Two Types of Artificial Tears
Lead Sponsor:
The Norwegian Dry Eye Clinic
Collaborating Sponsors:
Laboratoires Thea
Conditions:
Dry Eye Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyaluronic acid (HA), a natural component of the tear film, is a well-established active ingredient in artificial tears and has been reported to improve corneal and conjunctival staining in patients w...
Detailed Description
The patients will be treated with Thealoz Duo (at least 3 times daily) in one eye and with Hyabak (at least 3 times daily) in the other eye, based on randomization table. Both Hyabak and Thealoz Duo a...
Eligibility Criteria
Inclusion
- Dry Eye Severity Level (DESL) 1-3
- Equivalent between-eye DESL
Exclusion
- Ocular infection and/or non-linked inflammation
- Corneal pathology (except KSP)
- Corneal refractive surgery or cataract surgery within 6 months prior to the study
Key Trial Info
Start Date :
March 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT05356728
Start Date
March 11 2022
End Date
December 1 2023
Last Update
July 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Norwegian Dry Eye Clinic
Oslo, Norway, 0366